Target intelligence / Profile preview

Human immunodeficiency virus type 1 trans-activation response element (HIV-1 TAR element) (HIV-1 TAR element)

Target
HIV-1 TAR element
Molecular classification
RNA regulatory element, Viral RNA element
01

Overview

The HIV-1 trans-activation response (TAR) element is a 59-nucleotide RNA stem-loop structure located at the 5' end of all nascent HIV-1 transcripts (Karn & Stoltzfus, 2012, PMID: 22403101). It is encoded within the long terminal repeat (LTR) and serves as the essential binding site for the viral trans-activator protein, Tat (Bannwarth & Gatignol, 2005, PMID: 15638720). Upon binding, Tat recruits the host positive transcription elongation factor b (P-TEFb) complex, which phosphorylates the C-terminal domain of RNA polymerase II. This process converts the polymerase from a non-processive to a highly processive form, enabling the efficient elongation of viral mRNA. Without the TAR-Tat interaction, HIV-1 transcription is severely restricted, resulting in short, non-functional transcripts. Because of its critical role in viral replication and its highly conserved sequence, the TAR element is a significant target for antiviral drug development. Therapeutic strategies include small molecules and peptidomimetics designed to competitively inhibit Tat binding or disrupt the recruitment of host transcriptional machinery (Mousseau et al., 2015, PMID: 26361154). Targeting TAR is also explored in the context of block and lock strategies to enforce permanent viral latency.

Other names
TAR RNATrans-activation response elementHIV-1 TARTAR hairpinHIV-1 TAR element
02

Mechanism of action

Inhibition of Tat-TAR binding and disruption of P-TEFb recruitment to the viral promoter

03

Biological functions

Viral transcription elongationTat-mediated trans-activationViral replication
04

Disease associations

InfectionHIV-1 infectionAcquired immunodeficiency syndrome (AIDS)
05

Safety considerations

Off-target binding to host RNA (PMID: 15638720)Potential for viral resistance mutations (PMID: 22403101)Cellular toxicity of RNA-binding small molecules (PMID: 11030594)
06

Interacting drugs

Neomycin (PMID: 9409630)

4 more in the full profile.

07

Biomarkers

HIV-1 RNA (viral load)CD4+ T-cell countIntegrated proviral DNA levels (PMID: 26361154)

Beyond the preview

Go deeper on Human immunodeficiency virus type 1 trans-activation response element (HIV-1 TAR element) (HIV-1 TAR element).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus type 1 trans-activation response element (HIV-1 TAR element) (HIV-1 TAR element).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call